Markets
5.5
GSK to cut 1,217 jobs in Wallonia, pivots to oncology from vaccines
Published 21 h ago1 sourceEvidence: Reported
SeverityModerateLe MondeBE · GB
HealthReportedMediumDeveloping
4.7
FDA allows MabionCD20 as first-line therapy, trial shortened to 24 weeks
Oddifact SAS announces FDA consultation outcome permitting MabionCD20 as first-line therapy and shortening study duration to 24 weeks. This regulatory flexibility could accelerate development and market entry, but details on efficacy and safety remain undisclosed.
Score Breakdown
Mosaic Score4.7
Model confidence0.5
Significance0.5
Source credibility0.2
Intelligence Tags
Entities
United StatescountryPolandcountry
Related signals
8 foundHealth
5.2
AstraZeneca to Present Survival Data from Four Phase 3 Trials at ESMO 2026
Published 2 d ago1 sourceEvidence: Reported
SeverityModerateDagens IndustriLow-rated source
Health
5.0
Lawmakers urge FDA to close loophole on imported knockoff obesity drug retatrutide
Published 13 h ago1 sourceEvidence: Reported
SeverityModerateAssessedDeveloping storySTAT NewsLow-rated sourceUS
Health
4.8
MSD/Moderna Phase 3 Cancer Vaccine Trial Shows Improved Melanoma Survival
Published 2 d ago1 sourceEvidence: Reported
SeverityModerateAssessedDeveloping storyLe SoirLow-rated sourceUS · BE
Health
4.6
AI facial-analysis tool predicts cancer survival from patient selfie
Published 1 d ago1 sourceEvidence: Reported
SeverityModerateGuardian WorldLow-rated sourceUS
Health
2.0
Bolivian hospital receives lab equipment worth Bs 500k for cardiac, oncology tests
Published 9 h ago1 sourceEvidence: Reported
El DeberLow-rated sourceBO
Health
1.9
Gilead oral IBS drug eliminates symptoms in mid-stage trial
Published 1 d ago1 sourceEvidence: Reported
STAT NewsLow-rated source
Health
1.9
Bolivia: Breast cancer hits younger women, late diagnoses persist
Published 3 d ago1 sourceEvidence: Reported
El DeberLow-rated sourceBO